Market Cap : 1.03 B | Enterprise Value : 967.1 M | PE Ratio : At Loss | PB Ratio : |
---|
NYSE:MYOV has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:MYOV has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Myovant Sciences's Total Inventories for the three months ended in Mar. 2022 was $7.2 Mil. Myovant Sciences's Cost of Goods Sold for the three months ended in Mar. 2022 was $17.7 Mil. Hence, Myovant Sciences's Days Inventory for the three months ended in Mar. 2022 was 36.83.
The historical rank and industry rank for Myovant Sciences's Days Inventory or its related term are showing as below:
During the past 7 years, Myovant Sciences's highest Days Inventory was 484.99. The lowest was 36.09. And the median was 260.54.
MYOV's Days Inventory is ranked better thanMyovant Sciences's Days Inventory declined from Mar. 2021 (121.25) to Mar. 2022 (36.83).
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Total Inventories can be measured by Days Sales of Inventory (DSI).
Inventory Turnover measures how fast the company turns over its inventory within a year. Myovant Sciences's Inventory Turnover for the three months ended in Mar. 2022 was 2.48.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Myovant Sciences's Inventory-to-Revenue for the three months ended in Mar. 2022 was 0.12.
The historical data trend for Myovant Sciences's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Myovant Sciences's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Myovant Sciences's Days Inventory distribution charts can be found below:
* The bar in red indicates where Myovant Sciences's Days Inventory falls into.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Myovant Sciences's Days Inventory for the fiscal year that ended in Mar. 2022 is calculated as
Days Inventory (A: Mar. 2022 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (A: Mar. 2021 ) | + | Total Inventories (A: Mar. 2022 )) | / | count ) | / | Cost of Goods Sold (A: Mar. 2022 ) | * | Days in Period |
= | ( (2.611 | + | 7.584) | / | 2 ) | / | 51.551 | * | 365 |
= | 5.0975 | / | 51.551 | * | 365 | ||||
= | 36.09 |
Myovant Sciences's Days Inventory for the quarter that ended in Mar. 2022 is calculated as:
Days Inventory (Q: Mar. 2022 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (Q: Dec. 2021 ) | + | Total Inventories (Q: Mar. 2022 )) | / | count ) | / | Cost of Goods Sold (Q: Mar. 2022 ) | * | Days in Period |
= | ( (6.737 | + | 7.584) | / | 2 ) | / | 17.742 | * | 365 / 4 |
= | 7.1605 | / | 17.742 | * | 365 / 4 | ||||
= | 36.83 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An increase of Days Inventory may indicate the company's sales slowed.
1. Total Inventories can be measured by Days Sales of Inventory (DSI).
Myovant Sciences's Days Sales of Inventory for the three months ended in Mar. 2022 is calculated as
Days Sales of Inventory (DSI) | = | Total Inventories | / | Revenue | * | Days in Period |
= | 7.1605 | / | 57.567 | * | 365 / 4 | |
= | 11.35 |
2. Inventory Turnover measures how fast the company turns over its inventory within a year.
Myovant Sciences's Inventory Turnover for the three months ended in Mar. 2022 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Total Inventories |
= | 17.742 | / | 7.1605 | |
= | 2.48 |
3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Myovant Sciences's Inventory to Revenue for the three months ended in Mar. 2022 is calculated as
Inventory-to-Revenue | = | Total Inventories | / | Revenue |
= | 7.1605 | / | 57.567 | |
= | 0.12 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Thank you for viewing the detailed overview of Myovant Sciences's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Potter Myrtle S | director | 10 FINDERNE AVE BRIDGEWATER NJ 08807 |
Guinan Mark | director | C/O QUEST DIAGNOSTICS 500 PLAZA DRIVE SECAUCUS NJ 07094 |
Arjona Ferreira Juan Camilo | officer: Chief Medical Officer | C/O MYOVANT SCIENCES INC. 2000 SIERRA POINT PARKWAY, 9TH FLOOR BRISBANE CA 94005 |
Curran Terrie | director | C/O MYOVANT SCIENCES INC. 320 WEST 37TH STREET, 5TH FLOOR NEW YORK NY 10018 |
Gulfo Adele M. | director | ONE NEENAH CENTER, 4TH FLOOR P.O. BOX 669 NEENAH WI 54957 |
Sebelius Kathleen | director | C/O DERMIRA, INC. 275 MIDDLEFIELD ROAD, SUITE 150 MENLO PARK CA 94025 |
Lang Matthew | officer: General Counsel & Corp. Secy. | C/O MYOVANT SCIENCES INC. 2000 SIERRA POINT PARKWAY, 9TH FLOOR BRISBANE CA 94005 |
Sumitomo Chemical Co., Ltd. | 10 percent owner | 27-1, SHINKAWA 2-CHOME CHUO-KU TOKYO M0 104-8260 |
Sumitovant Biopharma Ltd. | 10 percent owner | C/O ROIVANT SCIENCES, INC. 320 WEST 37TH STREET, 5TH FLOOR NEW YORK NY 10018 |
Dainippon Sumitomo Pharma Co Ltd | 10 percent owner | 60 WALL STREET NEW YORK NY 10005 |
Seely Lynn | director, officer: Principal Executive Officer | 501 2ND STREET SUITE 211 SAN FRANCISCO CA 94107 |
Sablich Kim | officer: Chief Commercial Officer | C/O MYOVANT SCIENCES INC. 2000 SIERRA POINT PARKWAY BRISBANE CA 94005 |
Nomura Hiroshi | director | C/O MYOVANT SCIENCES INC. 2000 SIERRA POINT PARKWAY BRISBANE CA 94005 |
Roivant Sciences Ltd. | 10 percent owner | CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 |
Torti Frank | director | 2855 SAND HILL ROAD MENLO PARK CA 94025 |
Other Sources
By Zacks 2021-04-13
By Seekingalpha 2022-01-02
By Seekingalpha 2021-05-24
By Zacks 2021-02-11
By Seekingalpha 2021-02-11
By Zacks 2020-12-29
By Zacks 2021-09-10
By Fool 2021-07-28
By Seekingalpha 2021-01-19
By Zacks 2021-07-01
By Seekingalpha 2022-01-26
By Zacks 2021-10-26